Probiotics in Helicobacter pylori-induced peptic ulcer disease

Best Practice and Research: Clinical Gastroenterology

Volumn 30, Issue 1, 2016, Pages 99-109

  Boltin, Doron ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antibiotics; Gastritis; Helicobacter pylori; Lactobacillus; Peptic ulcer disease; Probiotics

Indexed keywords

ANTIBIOTIC AGENT; PROBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; BIFIDOBACTERIUM; DIARRHEA; DRUG EFFICACY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; INNATE IMMUNITY; LACTOBACILLUS; MONOTHERAPY; NONHUMAN; PEPTIC ULCER; SACCHAROMYCES; TREATMENT DURATION; GASTROINTESTINAL TRACT; HELICOBACTER INFECTIONS; INTESTINE FLORA; ISOLATION AND PURIFICATION; MICROBIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY;

ANTI-BACTERIAL AGENTS; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER; PROBIOTICS; PROSPECTIVE STUDIES;

EID: 84951768658     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2015.12.003     Document Type: Review

References (59)

1. G. Ianiro, J. Molina-Infante, and A. Gasbarrini Gastric microbiota Helicobacter 20 Suppl. 1 2015 68 71
2. S. Delgado, R. Cabrera-Rubio, A. Mira, A. Suárez, and B. Mayo Microbiological survey of the human gastric ecosystem using culturing and pyrosequencing methods Microb Ecol 65 2013 763 772
3. A.F. Andersson, M. Lindberg, H. Jakobsson, F. Bäckhed, P. Nyrén, and L. Engstrand Comparative analysis of human gut microbiota by barcoded pyrosequencing PLoS One 3 2008 e2836
4. E.M. Bik, P.B. Eckburg, S.R. Gill, K.E. Nelson, E.A. Purdom, F. Francois, and et al. Molecular analysis of the bacterial microbiota in the human stomach Proc Natl Acad Sci U S A 103 2006 732 737
5. X. Li, G.L. Wong, K. To, V.W. Wong, L.H. Lai, D.K. Chow, and et al. Bacterial microbiota profiling in gastritis without Helicobacter pylori infection or non-steroidal anti-inflammatory drug use PLoS One 4 2009 e7985
6. D. Boltin, and Y. Niv Mucins in gastric cancer - an update J Gastrointest Dig Syst 3 2013 15519
7. M. Saxelin, S. Tynkkynen, T. Mattila-Sandholm, and W.M. de Vos Probiotic and other functional microbes: from markets to mechanisms Curr Opin Biotechnol 16 2005 204 211
8. A. Saha, C.E. Hammond, C. Beeson, R.M. Peek, and A.J. Smolka Helicobacter pylori represses proton pump expression and inhibits acid secretion in human gastric mucosa Gut 59 2010 874 881
9. W. Schepp, K. Dehne, H. Herrmuth, K. Pfeffer, and C. Prinz Identification and functional importance of IL-1 receptors on rat parietal cells Am J Physiol 275 1998 G1094 G1105
10. J.P. Celli, B.S. Turner, N.H. Afdhal, S. Keates, I. Ghiran, C.P. Kelly, and et al. Helicobacter pylori moves through mucus by reducing mucin viscoelasticity Proc Natl Acad Sci U S A 106 2009 14321 14326
11. Van de Bovenkamp, H.B. Jeroen, J. Mahdavi, A.M. Korteland-Van Male, H.A. Büller, A.W.C. Einerhand, and et al. The MUC5AC glycoprotein is the primary receptor for Helicobacter pylori in the human stomach Helicobacter 8 2003 521 532
12. S. Tanaka, M. Mizuno, T. Maga, F. Yoshinaga, J. Tomoda, J. Nasu, and et al. H. pylori decreases gastric mucin synthesis via inhibition of galactosyltransferase Hepatogastroenterology 50 2003 1739 1742
13. A.J. Peterson, T.R. Menheniott, L. O'Connor, A.K. Walduck, J.G. Fox, K. Kawakami, and et al. Helicobacter pylori infection promotes methylation and silencing of trefoil factor 2, leading to gastric tumor development in mice and humans Gastroenterology 139 2010 2005 2017
14. M. Nakayama, M. Kimura, A. Wada, K. Yahiro, K. Ogushi, T. Niidome, and et al. Helicobacter pylori VacA activates the p38/activating transcription factor 2-mediated signal pathway in AZ-521 cells J Biol Chem 279 2004 7024 7028
15. Y. Yang, C. Chuang, H. Yang, C. Lu, and B. Sheu Lactobacillus acidophilus ameliorates H. pylori-induced gastric inflammation by inactivating the Smad7 and NFκB pathways BMC Microbiol 12 2012 38
16. H. Yu, W. Liu, Z. Chang, H. Shen, L. He, S. Wang, and et al. Probiotic BIFICO cocktail ameliorates Helicobacter pylori induced gastritis World J Gastroenterol 21 2015 6561 6571
17. De Keersmaecker, C.J. Sigrid, T.L.A. Verhoeven, J. Desair, K. Marchal, J. Vanderleyden, and et al. Strong antimicrobial activity of Lactobacillus rhamnosus GG against Salmonella typhimurium is due to accumulation of lactic acid FEMS Microbiol Lett 259 2006 89 96
18. S. Cunningham-Rundles, S. Ahrne, S. Bengmark, R. Johann-Liang, F. Marshall, L. Metakis, and et al. Probiotics and immune response Am J Gastroenterol 95 2000 S22 5
19. D.R. Mack, S. Michail, S. Wei, L. McDougall, and M.A. Hollingsworth Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression Am J Physiol 276 1999 G941 G950
20. M.H. Coconnier, V. Lievin, E. Hemery, and A.L. Servin Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB Appl Environ Microbiol 64 1998 4573 4580
21. N. Valeur, P. Engel, N. Carbajal, E. Connolly, and K. Ladefoged Colonization and Immunomodulation by lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract Appl Environ Microbiol 70 2004 1176 1181
22. C.P. Felley, I. Corthesy-Theulaz, J.L. Rivero, P. Sipponen, M. Kaufmann, P. Bauerfeind, and et al. Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man Eur J Gastroenterol Hepatol 13 2001 25 29
23. P.L. Conway, and S. Kjelleberg Protein-mediated adhesion of Lactobacillus fermentum strain 737 to mouse stomach squamous epithelium J Gen Microbiol 135 1989 1175 1186
24. J.K. Spinler, M. Taweechotipatr, C.L. Rognerud, C.N. Ou, S. Tumwasorn, and J. Versalovic Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens Anaerobe 14 2008 166 171
25. Y. Aiba, Y. Nakano, Y. Koga, K. Takahashi, and Y. Komatsu A highly acid-resistant novel strain of Lactobacillus johnsonii No. 1088 has antibacterial activity, including that against Helicobacter pylori, and inhibits gastrin-mediated acid production in mice Microbiologyopen 4 2015 465 474
26. B. Oh, B. Kim, J.W. Kim, J.S. Kim, S. Koh, B.G. Kim, and et al. The effect of probiotics on gut microbiota during the Helicobacter pylori eradication: randomized controlled trial Helicobacter 2015
27. M. Rugge, P. Correa, F. Di Mario, E. El-Omar, R. Fiocca, K. Geboes, and et al. OLGA staging for gastritis: a tutorial Dig Liver Dis 40 8 2008 650 658 10.1016/j.dld.2008.02.030
28. C. Kuo, S.S.W. Wang, C. Lu, H. Hu, F. Kuo, B. Weng, and et al. Long-Term Use of probiotic-containing yogurts is a safe way to prevent Helicobacter pylori: based on a Mongolian Gerbil's model Biochem Res Int 2013 2013 594561
29. D. Pantoflickova, I. Corthésy-Theulaz, G. Dorta, M. Stolte, P. Isler, F. Rochat, and et al. Favourable effect of regular intake of fermented milk containing Lactobacillus johnsonii on Helicobacter pylori associated gastritis Aliment Pharmacol Ther 18 2003 805 813
30. M.H. Emara, S.Y. Mohamed, and H.R. Abdel-Aziz Lactobacillus reuteri in management of Helicobacter pylori infection in dyspeptic patients: a double-blind placebo-controlled randomized clinical trial Ther Adv Gastroenterol 7 2014 4 13
31. R. Francavilla, E. Lionetti, S.P. Castellaneta, A.M. Magistà, G. Maurogiovanni, N. Bucci, and et al. Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study Helicobacter 13 2008 127 134
32. S.N. Elliott, A. Buret, W. McKnight, M.J. Miller, and J.L. Wallace Bacteria rapidly colonize and modulate healing of gastric ulcers in rats Am J Physiol 275 1998 G425 G432
33. D.Y. Graham Editorial - avoiding unethical Helicobacter pylori clinical trials: susceptibility-based studies and probiotics as adjuvants Helicobacter 20 2015 321 325
34. P. Michetti, G. Dorta, P.H. Wiesel, D. Brassart, E. Verdu, M. Herranz, and et al. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans Digestion 60 1999 203 209
35. I. Sakamoto, M. Igarashi, K. Kimura, A. Takagi, T. Miwa, and Y. Koga Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans J Antimicrob Chemother 47 2001 709 710
36. A. Cats, E.J. Kuipers, M.A.R. Bosschaert, R.G.J. Pot, C.M.J.E. Vandenbroucke-Grauls, and J.G. Kusters Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects Aliment Pharmacol Ther 17 2003 429 435
37. M. Gotteland, and S. Cruchet Suppressive effect of frequent ingestion of Lactobacillus johnsonii La1 on Helicobacter pylori colonization in asymptomatic volunteers J Antimicrob Chemother 51 2003 1317 1319
38. S. Cruchet, M.C. Obregon, G. Salazar, E. Diaz, and M. Gotteland Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children Nutrition 19 2003 716 721
39. M. Gotteland, L. Poliak, S. Cruchet, and O. Brunser Effect of regular ingestion of Saccharomyces boulardii plus inulin or Lactobacillus acidophilus LB in children colonized by Helicobacter pylori Acta Paediatr 94 2005 1747 1751
40. K. Imase, A. Tanaka, K. Tokunaga, H. Sugano, H. Ishida, and S. Takahashi Lactobacillus reuteri tablets suppress Helicobacter pylori infection-a double-blind randomised placebo-controlled cross-over clinical study Kansenshogaku Zasshi 81 2007 387 393
41. K. Miki, Y. Urita, F. Ishikawa, T. Iino, H. Shibahara-Sone, R. Akahoshi, and et al. Effect of Bifidobacterium bifidum fermented milk on Helicobacter pylori and serum pepsinogen levels in humans J Dairy Sci 90 2007 2630 2640
42. M. Gotteland, M. Andrews, M. Toledo, L. Muñoz, P. Caceres, A. Anziani, and et al. Modulation of Helicobacter pylori colonization with cranberry juice and Lactobacillus johnsonii La1 in children Nutrition 24 2008 421 426
43. R. Rosania, M. Filomena Minenna, F. Giorgio, A. Facciorusso, V de Francesco, C. Hassan, and et al. Probiotic multistrain treatment may eradicate Helicobacter pylori from the stomach of dyspeptics IADT 11 2012 244 249
44. H. Mehling, and A. Busjahn Non-viable Lactobacillus reuteri DSMZ 17648 (Pylopass) as a new approach to Helicobacter pylori control in humans Nutrients 5 2013 3062 3073
45. R. Francavilla, L. Polimeno, A. Demichina, G. Maurogiovanni, B. Principi, G. Scaccianoce, and et al. Lactobacillus reuteri strain combination in Helicobacter pylori infection: a randomized, double-blind, placebo-controlled study J Clin Gastroenterol 48 2014 407 413
46. M.P. Dore, M. Cuccu, G.M. Pes, A. Manca, and D.Y. Graham Lactobacillus reuteri in the treatment of Helicobacter pylori infection Intern Emerg Med 9 2014 649 654
47. Y. Tindberg, M. Blennow, and M. Granstrom Clinical symptoms and social factors in a cohort of children spontaneously clearing Helicobacter pylori infection Acta Paediatr 88 1999 631 635
48. J.L. Tong, Z.H. Ran, J. Shen, C.X. Zhang, and S.D. Xiao Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy Aliment Pharmacol Ther 25 2007 155 168
49. J. Zou, J. Dong, and X. Yu Meta-analysis: Lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication Helicobacter 14 2009 97 107
50. A. Sachdeva, and J. Nagpal Effect of fermented milk-based probiotic preparations on Helicobacter pylori eradication: a systematic review and meta-analysis of randomized-controlled trials Eur J Gastroenterol Hepatol 21 2009 45 53
51. H. Szajewska, A. Horvath, and A. Piwowarczyk Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment Aliment Pharmacol Ther 32 2010 1069 1079
52. Z. Wang, Q. Gao, and J. Fang Meta-analysis of the efficacy and safety of Lactobacillus-containing and Bifidobacterium-containing probiotic compound preparation in Helicobacter pylori eradication therapy J Clin Gastroenterol 47 2013 25 32
53. X. Zheng, L. Lyu, and Z. Mei Lactobacillus-containing probiotic supplementation increases Helicobacter pylori eradication rate: evidence from a meta-analysis Rev Esp Enferm Dig 105 2013 445 453
54. S. Li, X. Huang, J. Sui, S. Chen, Y. Xie, Y. Deng, and et al. Meta-analysis of randomized controlled trials on the efficacy of probiotics in Helicobacter pylori eradication therapy in children Eur J Pediatr 173 2014 153 161
55. Y. Dang, J.D. Reinhardt, X. Zhou, and G. Zhang The effect of probiotics supplementation on Helicobacter pylori eradication rates and side effects during eradication therapy: a meta-analysis PLoS One 9 2014 e111030
56. R. Zhu, K. Chen, Y. Zheng, H. Zhang, J. Wang, Y. Xia, and et al. Meta-analysis of the efficacy of probiotics in Helicobacter pylori eradication therapy World J Gastroenterol 20 2014 18013 18021
57. M. Zhang, W. Qian, Y. Qin, J. He, and Y. Zhou Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis World J Gastroenterol 21 2015 4345 4357
58. Y. Gong, Y. Li, and Q. Sun Probiotics improve efficacy and tolerability of triple therapy to eradicate Helicobacter pylori: a meta-analysis of randomized controlled trials Int J Clin Exp Med 8 2015 6530 6543
59. B. Li, D.E. Threapleton, J. Wang, J. Xu, J. Yuan, C. Zhang, and et al. Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis BMJ 351 2015 h4052